Pregnant women have a lower risk of gestational diabetes and unhealthy weight gain in cities that tax sugary drinks, according to a first-of-its-kind study of more than 5 million women by UCSF.
A new collaboration between UC Davis Health and Propeller Health will offer personalized treatment for high-risk patients with asthma and chronic obstructive pulmonary disease.
Gordon Moore, the co- founder of the Betty Irene Moore School of Nursing at UC Davis and Intel Corporation, is remembered as a brilliant scientist, business leader and philanthropist.
Thermo Fisher Scientific Inc. and UCSF will accelerate advanced cell therapies for difficult to treat conditions like cancer from a new manufacturing facility.
The FDA has approved a new treatment for candidiasis called rezafungin for injection. The approval is based on a clinical trial in which George Thompson served as principal investigator.
Now that the School of Medicine’s new I-EXPLORE curriculum has been fully implemented for students in all four years, leaders within the Office of Medical Education paused this week to celebrate their achievements.
